Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell-surface sialic acids are a family of nine-carbon acidic monosaccharides typically found at the terminal positions of N-linked and O-linked glycans on glycoproteins and glycolipids (Varki A, 2008). They are essential components of the "sialome," playing pivotal roles in cell-cell recognition, molecular masking, and the regulation of the innate and adaptive immune systems (Cohen M, et al., 2010). By interacting with Sialic acid-binding immunoglobulin-type lectins (Siglecs), these residues function as "self-associated molecular patterns" (SAMPs) that suppress overactive immune responses (Läubli H, et al., 2020). In oncology, many tumors exhibit hypersialylation, which facilitates immune evasion by engaging inhibitory Siglecs on natural killer (NK) cells and macrophages (Pearce OM, et al., 2016). Furthermore, sialic acids serve as critical attachment points for numerous pathogens, most notably the influenza virus, which uses hemagglutinin to bind these residues for host cell entry (Skehel JJ, et al., 2000). Therapeutic interventions include neuraminidase inhibitors that prevent viral spread and emerging glyco-immune checkpoint inhibitors designed to disrupt the sialic acid-Siglec axis in the tumor microenvironment (Zhou X, et al., 2020).
Inhibition of viral neuraminidase to prevent the cleavage of terminal sialic acid residues from host cell surfaces, thereby trapping viral progeny; blockade of sialic acid-binding receptors like P-selectin to prevent cell adhesion; and disruption of the sialic acid-Siglec immune checkpoint to enhance anti-tumor immunity (Varki A, 2008; Zhou X, et al., 2020).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell-surface sialic acid (Sia) (Sia).